Although cell invasion is a necessary early step in
cancer metastasis, its regulation is not well understood. We have previously shown, in human
prostate cancer, that
transforming growth factor beta (
TGFbeta)-mediated increases in cell invasion are dependent upon activation of the
serine/threonine kinase,
p38 MAP kinase. In the current study, downstream effectors of
p38 MAP kinase were sought by first screening for
proteins phosphorylated after
TGFbeta treatment, only in the absence of chemical inhibitors of
p38 MAP kinase. This led us to investigate
mitogen-activated protein kinase-activated
protein kinase 2 (
MAPKAPK2), a known substrate of
p38 MAP kinase, as well as
heat-shock protein 27 (HSP27), a known substrate of
MAPKAPK2, in both PC3 and PC3-M human prostate cells. After transient transfection, wild-type
MAPKAPK2 and HSP27 both increased
TGFbeta-mediated
matrix metalloproteinase type 2 (MMP-2) activity, as well as cell invasion, which in turn was inhibited by
SB203580, an inhibitor of
p38 MAP kinase. Conversely, dominant-negative
MAPKAPK2 blocked phosphorylation of HSP27, whereas dominant-negative
MAPKAPK2 or mutant, non-phosphorylateable, HSP27 each blocked
TGFbeta-mediated increases in MMP-2, as well as cell invasion. Similarly, knock down of
MAPKAPK2, HSP27 or both together, by
siRNA, also blocked
TGFbeta-mediated cell invasion. This study demonstrates that both
MAPKAPK2 and HSP27 are necessary for
TGFbeta-mediated increases in MMP-2 and cell invasion in human
prostate cancer.